Charity Teams Up with Software Company to 'Gamify' Cancer

The United Kingdom's largest cancer charity is teaming up with a British software company to develop a game they hope will generate data regarding the causes of cancer.

Cancer Research UK has announced a partnership with an England-based software agency called Guerilla Tea. Their hope is to develop a game they are currently calling GeneGame. By playing it, they hope the public will help analyze cancer data and contribute to determining some of the causes of cancer.

The human touch

One of the reasons for the game development is by using genetics to treat some cancers, researchers have created "terabytes upon petabytes of data requiring analysis" and the quickest, most efficient way to analyze all the data is by crowdsourcing it through gaming. The key is that the data cannot be analyzed by computer – it requires the human eye.

A representative from Cancer Research UK said:

We're right at the start of a world-first initiative that will result in a game that we hope hundreds of thousands of people across the globe will want to play over and over again and, at the same time, generate robust scientific data analysis.

Cancer research in an app

While there are no details on what the game will be like, it will come in the form of a smartphone app. It will likely work in much the same way that Cancer Research UK launched Cell Slider last year, which invited the public to examine and classify breast cancer samples.

GeneGame is set to be released in the United Kingdom sometime in 2013.

Source: MNT

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap